PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Cutler, Andrew J
ED  - Brecher, Martin
ED  - Datto, Catherine
ED  - Weisler, Richard H
ED  - Suppes, Trisha
ED  - Joyce, Meredith
ED  - Katzman, Martin A
TI  - Quetiapine for the Treatment of Depression Associated with Bipolar Disorder—Selected Posters
DP  - 2008 Nov 01
TA  - MD Conference Express
PG  - 11--11
VI  - 8
IP  - 3
4099  - http://mdc.sagepub.com/content/8/3/11.short
4100  - http://mdc.sagepub.com/content/8/3/11.full
AB  - Quetiapine is approved for the treatment of acute mania and depression associated with bipolar disorder, a complex and debilitating illness that has a lifetime prevalence between 1% to 4% in the US [Bowden CL et al. J Clin Psychiatry 2005]. Data from several posters showed the superiority of extended release quetiapine as a treatment for major depressive disorder and generalized anxiety disorder associated with bipolar I/II disorders versus placebo in patients aged 18 to 65 years.